Endocrinology

Blood glucose monitoring is an important part of patient care no matter where it is done, but it can be particularly important in hospital settings.

The field of diabetes care is continually moving forward. Even as data was being presented at this year's meeting of the American Diabetes Association the future was at the forefront of many people's minds in an effort to help these patients even more.

Even as gastric bypass continues to be a proven surgical option in the fight against the obesity epidemic work still remains to find a therapeutic option for this patient population as well.

There is no question that hunger can affect a person's life, a recent study looked at the scientific aspect of this discussion and what doctors can do to help patients with this challenge.

Especially for children with diagnosed with type 1 diabetes their journey with the condition will last decades affecting not only themselves but those around them. This is also true for patients with type 2 diabetes and how they confront these challenges can affect their life outside of diabetes as well.

Patients with type 2 diabetes are especially at risk for getting the hepatitis B infection, and a new vaccine proved to work better than the current one during a phase III trial.

“Early diabetic kidney disease (DKD), including increased albumin excretion and renal hyperfiltration (HF), is common in youth with type 2 diabetes,†a collaborative team of researchers began in a poster session at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

IBM Watson Health is working on several projects of their own as well as with partners in the field to move the treatment of diabetes forward in an effort to hep as many patients as possible.

At the recent ASCO conference in Chicago it was announced that Watson Health would be used to help with cancer treatment. A similar announcement was made at the American Diabetes Association's annual meeting in New Orleans.

As the treatment of diabetes becomes more complicated with a multitude of options on the market a long time member of the medical technology community is taking a big step to help fight this epidemic.

Everyone needs an adequate amount of sleep every night, but it should especially be a priority in pregnant women. However, there is a fine line between too much and too little sleep, but either way, both sides of the spectrum have an increase risk in gestational diabetes.

The obesity epidemic continues to grow in this country leaving the medical community to find new ways to help this patient population.

Maternal health just got that much more important as new research finds obesity contributes to chronic kidney disease risk in children.

Many healthcare providers have been pushing for the approval of insulin degludec/liraglutide (IDegLira) and the latest safety and efficacy results could help finally do that.

Not much is known about the relationship between oral contraceptives use and diabetes, but this untapped area got the spotlight during a session at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

Patients with type 1 diabetes can safely lower their blood glucose levels and hypoglycemia in a home setting with the dual hormone (glucagon and insulin) bionic pancreas, a new study revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

A fair amount of women who are diagnosed with gestational diabetes take active measures to lose weight – but what clinical outcomes does that have?

Vitamin D and diabetes have a rocky relationship, but new insight was revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?

Statistics coming from controlled trials can be challenging to apply to the real-world. But a new study assessing the use of dapagliflozin for type 2 diabetes in real clinical use yielded important insight.

New research presented at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana makes a case for autologous transplantation.

Pig cell transplantation could take the place of a blood glucose level-improving surgery for patients with type 1 diabetes.

Study results show that patients with diabetic macular edema are more likely to improve with treatment by a combination of ranibizumab and AKB-9778, as compared to treatment with either alone.

In this Medical News Minute, Dr. Bobby Lazzara summarizes a study on the effects of a very-low-calorie diet on blood glucose.

Research suggests that lipid screening appears to remain particularly underutilized in adults taking antipsychotic medications, despite improvements in recent years in the use of diabetes screening in this patient population.

New consensus guidelines for the treatment of type 2 diabetes mellitus (T2DM) recommend, for the first time, that metabolic surgery be recommended or considered as an intervention for many obese patients.

As obesity becomes a growing problem, doctors are turning to weight loss surgeries to help their patients return to a healthy quality of life. Work is being done to make these procedures as non-invasive as possible to help with the recovery and postoperative times.

Investigators from Washington University and Harvard University have used stem cells derived from patients with type 1 diabetes mellitus to produce cells that secrete insulin in both cultures and mice.

The MD Magazine editors rounded up the 10 best stories from May – did you read them all?

When treating patients with a variety of conditions it can be easy for the lines of care to be blurred, this is particularly true when treating patients with conditions like diabetes and heart failure among others.